The Management of Advanced Testicular Teratoma
- 1 July 1988
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 62 (1), 63-68
- https://doi.org/10.1111/j.1464-410x.1988.tb04268.x
Abstract
Summary— Of 320 patients with metastatic malignant non‐seminomatous germ cell tumours of the testis (NSGCT) treated with chemotherapy, 266 (83%) are alive and well after a median follow‐up of 39 months. Deaths from treatment‐related causes occurred in 9 patients and were related to intensity of chemotherapy. Relapse after chemotherapy was rare except in presentations with large tumour volume and high serum marker concentrations and a strategy has been developed of risk‐related choice of chemotherapy in order to reduce treatment toxicity in good prognosis sub‐groups of patients.This publication has 12 references indexed in Scilit:
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?European Journal of Cancer and Clinical Oncology, 1986
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- CHILDREN FATHERED BY MEN TREATED FOR TESTICULAR CANCERThe Lancet, 1985
- Curative testis cancer therapy: psychosocial sequelae.Journal of Clinical Oncology, 1985
- Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycinCancer, 1984
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Bleomycin combination chemotherapy in the management of testicular neoplasiaCancer, 1975